Published in Cancer Immunol Immunother on May 04, 2004
Ovarian cancer immunotherapy: opportunities, progresses and challenges. J Hematol Oncol (2010) 1.16
Targeted treatment of recurrent platinum-resistant ovarian cancer: current and emerging therapies. Cancer Manag Res (2010) 1.08
Combined yeast-derived beta-glucan with anti-tumor monoclonal antibody for cancer immunotherapy. Exp Mol Pathol (2009) 1.07
Immunotherapy in ovarian cancer. Hum Vaccin Immunother (2012) 0.99
Monoclonal antibodies in gynecological cancer: a critical point of view. Clin Dev Immunol (2011) 0.78
Antibodies elicited by the first non-viral prophylactic cancer vaccine show tumor-specificity and immunotherapeutic potential. Sci Rep (2016) 0.76
Therapeutic targets and new directions for antibodies developed for ovarian cancer. MAbs (2016) 0.75
Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression. Oncol Lett (2017) 0.75
Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol (2000) 9.70
The measurement of satisfaction with healthcare: implications for practice from a systematic review of the literature. Health Technol Assess (2002) 6.37
Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science (1996) 5.55
Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology (1997) 5.53
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer (2006) 4.93
Allogeneic bone marrow transplantation in multiple myeloma. European Group for Bone Marrow Transplantation. N Engl J Med (1991) 4.17
a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med (2000) 4.15
The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell (1995) 4.13
Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J Clin Oncol (1997) 3.61
Collecting morbidity data in general practice: the Somerset morbidity project. BMJ (1996) 3.08
The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Technol Assess (1999) 2.83
Tyro-3 family receptors are essential regulators of mammalian spermatogenesis. Nature (1999) 2.80
Predicting successful vaginal birth after Cesarean section using a model based on Cesarean scar features examined by transvaginal sonography. Ultrasound Obstet Gynecol (2013) 2.73
Natural history of stage IV epithelial ovarian cancer. J Clin Oncol (1999) 2.52
Isolation of a polymorphic DNA segment unique to human chromosome 7 by molecular cloning of hybrid cell DNA. Mol Gen Genet (1983) 2.43
The safety and side effects of monoclonal antibodies. Nat Rev Drug Discov (2010) 2.23
Should women carry their antenatal records? Br Med J (Clin Res Ed) (1986) 2.17
Postoperative pulmonary complications. Epidural analgesia using bupivacaine and opioids versus parenteral opioids. Anesthesiology (1993) 2.14
A simple physicochemical micromethod for determining fixed anionic groups in connective tissue. Biochim Biophys Acta (1970) 1.98
Bio-Electric Correlates of Human Ovulation. Yale J Biol Med (1937) 1.97
A melanocyte-specific gene, Pmel 17, maps near the silver coat color locus on mouse chromosome 10 and is in a syntenic region on human chromosome 12. Proc Natl Acad Sci U S A (1991) 1.97
The acquisition of the voicing contrast in English: study of voice onset time in word-initial stop consonants. J Child Lang (1980) 1.95
Induction of remission in hepatocellular carcinoma with doxorubicin. Lancet (1978) 1.86
A randomized controlled trial of the provision of a social support service during pregnancy: the South Manchester Family Worker Project. Br J Obstet Gynaecol (1989) 1.81
Accident & Emergency Department's response to patients' inquiries by telephone. J R Soc Med (1991) 1.74
Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study. J Hepatol (1996) 1.73
Brain alpha-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron (1990) 1.72
Retrotransposon evolution in diverse plant genomes. Genetics (2000) 1.68
Whole-genome sequencing reveals complex mechanisms of intrinsic resistance to BRAF inhibition. Ann Oncol (2014) 1.64
Catabolites of chlorophyll in senescing barley leaves are localized in the vacuoles of mesophyll cells. Proc Natl Acad Sci U S A (1988) 1.61
Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer. J Clin Oncol (2002) 1.55
Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet (1997) 1.55
A rational approach to shift work in emergency medicine. Ann Emerg Med (1992) 1.53
Radiological predictors of cytoreductive outcomes in patients with advanced ovarian cancer. BJOG (2014) 1.47
Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients. J Clin Oncol (1998) 1.46
Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med (1997) 1.44
Evidence in support of a role for plant-mediated proteolysis in the rumens of grazing animals. Br J Nutr (2005) 1.44
Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity. J Clin Oncol (1995) 1.43
Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol (1990) 1.43
Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques. Am J Kidney Dis (2002) 1.42
Praziquantel. Med Res Rev (1983) 1.41
Co-incidental diagnosis of an extradural abscess while siting an extradural catheter for postoperative analgesia. Br J Anaesth (1998) 1.39
The real costs of emesis--an economic analysis of ondansetron vs. metoclopramide in controlling emesis in patients receiving chemotherapy for cancer. Eur J Cancer (1993) 1.39
What proportion of isotope injected does the child receive in dynamic renal scanning? Nucl Med Commun (1992) 1.38
Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus. J Exp Med (1990) 1.38
Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine. J Virol (1990) 1.35
The Wilms tumor suppressor gene wt1 is required for development of the spleen. Curr Biol (1999) 1.34
Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: results of a large European phase II study. J Clin Oncol (1996) 1.33
A phase I study of the safety and tolerability of olaparib (AZD2281, KU0059436) and dacarbazine in patients with advanced solid tumours. Br J Cancer (2011) 1.31
Hepatitis B variant in Europe. Lancet (1988) 1.31
Chemotherapy in advanced ovarian cancer: four systematic meta-analyses of individual patient data from 37 randomized trials. Advanced Ovarian Cancer Trialists' Group. Br J Cancer (1998) 1.27
Induction of rabies virus-specific T-helper cells by synthetic peptides that carry dominant T-helper cell epitopes of the viral ribonucleoprotein. J Virol (1989) 1.27
The efficacy of praziquantel against cestodes in animals. Z Parasitenkd (1977) 1.26
Recent advances: oncology. BMJ (1999) 1.26
Adaptations of glutathione antioxidant system to endurance training are tissue and muscle fiber specific. Am J Physiol (1997) 1.25
Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood (2005) 1.24
Monoclonal antibodies and human tumor pathology. Hum Pathol (1982) 1.24
Cost effectiveness of interferon alpha or peginterferon alpha with ribavirin for histologically mild chronic hepatitis C. Gut (2005) 1.24
Structure, expression, and activity of Tyro 3, a neural adhesion-related receptor tyrosine kinase. Oncogene (1994) 1.24
Function of indoleamine 2,3-dioxygenase in corneal allograft rejection and prolongation of allograft survival by over-expression. Eur J Immunol (2006) 1.24
De novo evolution of satellite DNA on the rye B chromosome. Genetics (2000) 1.24
Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection. Gut (2003) 1.23
Docetaxel and cisplatin in combination as first-line chemotherapy for advanced epithelial ovarian cancer. Scottish Gynaecological Cancer Trials Group. J Clin Oncol (1999) 1.22
Targeted anti-vascular therapies for ovarian cancer: current evidence. Br J Cancer (2013) 1.21
Long-term follow-up of the hepatitis C HENCORE cohort: response to therapy and occurrence of liver-related complications. J Viral Hepat (2007) 1.21
Superoxide dismutase gene expression is activated by a single bout of exercise in rat skeletal muscle. Pflugers Arch (2001) 1.20
Biological characterization of human monoclonal antibodies to rabies virus. J Virol (1990) 1.20
Chemotherapy for ovarian cancer--a consensus statement on standard practice. Br J Cancer (1998) 1.19
Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology (2006) 1.18
Oxidative stress and aging. Role of exercise and its influences on antioxidant systems. Ann N Y Acad Sci (1998) 1.17
ChlVPP combination chemotherapy for Hodgkin's disease: long-term results. Br J Cancer (1990) 1.17
Chronic cough in a hospital population; its relationship to atopy and defects in host defence. Arch Dis Child (1989) 1.16
Inhibition of NF-kappa B and oxidative pathways in human dendritic cells by antioxidative vitamins generates regulatory T cells. J Immunol (2005) 1.15
Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein. J Gen Virol (1989) 1.15
Changes in Cesarean section scar dimensions during pregnancy: a prospective longitudinal study. Ultrasound Obstet Gynecol (2013) 1.14
The value of an improved scoring system (CGHQ) for the General Health Questionnaire in a representative community sample. Psychol Med (1988) 1.14
Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest Ophthalmol Vis Sci (2004) 1.13
Evaluation of an integrated community antenatal clinic. J R Coll Gen Pract (1987) 1.13
Action of caffeine on calcium transport by isolated fractions of myofibrils, mitochondria, and sarcoplasmic reticulum from rabbit heart. Circ Res (1978) 1.11
Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut (2003) 1.11
Mapping of von Hippel-Lindau disease to chromosome 3p confirmed by genetic linkage analysis. J Neurol Sci (1990) 1.10
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat (2013) 1.10
Expression of the c-erbB-3/HER-3 and c-erbB-4/HER-4 growth factor receptors and their ligands, neuregulin-1 alpha, neuregulin-1 beta, and betacellulin, in normal endometrium and endometrial cancer. Clin Cancer Res (1999) 1.10
Effectiveness of interferon alfa on incidence of hepatocellular carcinoma and decompensation in cirrhosis type C. European Concerted Action on Viral Hepatitis (EUROHEP). J Hepatol (1997) 1.09
Re: economic evaluation of robot-assisted hysterectomy: a cost-minimisation analysis. BJOG (2015) 1.09
Preparation of insoluble collagen from human cartilage. Biochem J (1973) 1.09
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib. Br J Cancer (2009) 1.09
Two new cases of FMR1 deletion associated with mental impairment. Am J Hum Genet (1995) 1.08
Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients. Eur J Immunol (2001) 1.08
Superoxide dismutase gene expression in skeletal muscle: fiber-specific adaptation to endurance training. Am J Physiol (1999) 1.08
The acquisition of the voicing contrast in Spanish: a phonetic and phonological study of word-initial stop consonants. J Child Lang (1980) 1.08
'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study Group. Ann Oncol (1996) 1.07
Melphalan and total body irradiation (TBI) versus cyclophosphamide and TBI as conditioning for allogeneic matched sibling bone marrow transplants for acute myeloblastic leukaemia in first remission. Bone Marrow Transplant (1988) 1.07
Demonstration of the ascending aorta in infective endocarditis by intravenous digital subtraction angiography. Br Heart J (1988) 1.06
The genetic epidemiology of early-onset epithelial ovarian cancer: a population-based study. Am J Hum Genet (1999) 1.06
Multistep ionization of argon clusters in intense femtosecond extreme ultraviolet pulses. Phys Rev Lett (2008) 1.06
Autoantibodies found after thymectomy in a patient later developing myasthenia gravis. J Neurol Neurosurg Psychiatry (1965) 1.04
Evaluation research in public health: barriers to the production and dissemination of outcomes data. Can J Public Health (1997) 1.03